產(chǎn)品描述
PCI-24781 (Abexinostat) is a new pan-HDAC inhibitor mainly targeting HDAC1 (Ki: 7 nM), also have moderate inhibitory for HDACs 2, 3, 6, and 10 and greater than 40-fold selectivity against HDAC8. Phase 1/2.
產(chǎn)品價(jià)格
貨號(hào) | 規(guī)格 | 價(jià)格 |
CC1246 |
5mg |
1040.00 元 |
CC1246 | 10mg | 1945.00 元 |
CC1246 | 50mg | 5874.00 元 |
化學(xué)數(shù)據(jù)
分子量Molecular Weight (MW) | 397.42 | |
---|---|---|
化學(xué)式Formula |
C21H23N3O5 |
|
CAS號(hào)CAS No. | 783355-60-2 | |
溶解性Solubility (25°C) | 二甲基亞砜DMSO |
80 mg/mL (201.30 mM) |
水Water | Insoluble | |
乙醇Alcohol | Insoluble |
制備儲(chǔ)備液
濃度/溶劑體積(DMSO)/質(zhì)量 | 1 mg | 5 mg | 10 mg |
1 mM | 2.5162 mL | 12.5811 mL | 25.1623 mL |
5 mM | 0.5032 mL | 2.5162 mL | 5.0325 mL |
10 mM | 0.2516 mL | 1.2581 mL | 2.5162 mL |
50 mM | 0.0503 mL | 0.2516 mL | 0.5032 mL |